Lv1
50 积分 2025-11-28 加入
Association between pembrolizumab-related thyroid adverse events and outcomes in early-stage triple-negative breast cancer patients
3个月前
已关闭
Association between pembrolizumab-related thyroid adverse events and outcomes in early-stage triple negative breast cancer patients
5个月前
已完结
Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer
5个月前
已完结
Association between pembrolizumab-related thyroid adverse events and outcomes in early-stage triple negative breast cancer patients
5个月前
已关闭
Meta-Analysis: Immune-Related Adverse Events Are Associated With Improved Effectiveness of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
5个月前
已完结
Efficacy and safety of Huachansu capsule as adjuvant therapy for breast cancer: A systematic review and meta-analysis of randomized controlled trials
8个月前
已完结
Long-term overall survival with dual CTLA-4 and PD-L1 or PD-1 blockade and biomarker-based subgroup analyses in patients with advanced non-small-cell lung cancer: a systematic review and reconstructed individual patient data meta-analysis
9个月前
已完结
皖公网安备34019202002308
